How we do it

Everyone at GSK focuses on three priorities: Innovation, Performance, Trust


We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.


adjusted R&D investment in 2020


new medicines in development at FY 2020


new vaccines in development at FY 2020




We deliver growth by investing effectively in our business, developing our people and executing competitively.


turnover in 2020


adjusted operating profit in 2020


free cash flow in 2020


dividends paid in 2020



We are a responsible company - using our science and technology to address health needs, we are focused on making our products affordable and available, and being a modern employer. 


employee engagement score on our latest employee survey


donated in 2020 to community health programmes


in Access to Medicines Index since the assessment began in 2008